Hiroyuki Kanno
- Oncology top 5%
- Viral-associated cancers and disorders 20
-
- Lymphoma Diagnosis and Treatment 28
-
- Cardiac tumors and thrombi 4
- Immunology top 10%
- Immune Cell Function and Interaction 13
-
- Vasculitis and related conditions 8
- Sarcoma Diagnosis and Treatment 5
-
- Eosinophilic Disorders and Syndromes 8
-
- Asthma and respiratory diseases 4
- Co-authors
- Masahiko OhsawaKatsuyuki AozasaNorifumi NakaAtsumasa UchidaY. TomitaYasuhiko TomitaTakashi SawaiAkira Myoui
- Partner nations
- JapanUnited StatesChile
In The Last Decade
Hiroyuki Kanno
84 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 109
- Oncology 941
- Pathology and Forensic Medicine 418
- Cardiology and Cardiovascular Medicine 367
- Immunology 323
- Pulmonary and Respiratory Medicine 465
Countries citing papers authored by Hiroyuki Kanno
This map shows the geographic impact of Hiroyuki Kanno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Kanno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Kanno more than expected).
Fields of papers citing papers by Hiroyuki Kanno
This network shows the impact of papers produced by Hiroyuki Kanno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Kanno. The network helps show where Hiroyuki Kanno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroyuki Kanno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 5 | |
| 4 | 2020 | 0 | |
| 5 | 2020 | 3 | |
| 6 | 2017 | 10 | |
| 7 | 2017 | 32 | |
| 8 | 2013 | 3 | |
| 9 | 2011 | 13 | |
| 10 | 2011 | 8 | |
| 11 | 2011 | 10 | |
| 12 | 2005 | 23 | |
| 13 | 2005 | 15 | |
| 14 | 2005 | 25 | |
| 15 | 2000 | 39 | |
| 16 | 1999 | 43 | |
| 17 | EPSTEIN-BARR VIRUS AND MALIGNANT LYMPHOMA | 1998 | 1 |
| 18 | 1998 | 8 | |
| 19 | [Results of mutation analyses of von Hippel-Lindau disease gene in Japanese patients: comparison with results in United States and United Kingdom]. | 1995 | 7 |
| 20 | 1995 | 130 |
About Hiroyuki Kanno
Hiroyuki Kanno is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology, having authored 91 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (28 papers), Viral-associated cancers and disorders (20 papers), Immune Cell Function and Interaction (13 papers), Eosinophilic Disorders and Syndromes (8 papers), Vasculitis and related conditions (8 papers), Sarcoma Diagnosis and Treatment (5 papers), Cardiac tumors and thrombi (4 papers) and Asthma and respiratory diseases (4 papers). The work is most often cited by research in Oncology (941 citations), Pathology and Forensic Medicine (418 citations) and Cardiology and Cardiovascular Medicine (367 citations). Hiroyuki Kanno has collaborated with scholars based in Japan, United States and Chile. Frequent co-authors include Masahiko Ohsawa, Katsuyuki Aozasa, Norifumi Naka, Atsumasa Uchida, Y. Tomita, Katsuyuki Aozasa, Yasuhiko Tomita, Takashi Sawai, Akira Myoui and Masahiro Yasunaga. Their work appears in journals such as Nature Communications, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.